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OBJECTIVE—Adipocyte inﬁltration of the musculoskeletal sys-
tem is well recognized as a hallmark of aging, obesity, and type 2
diabetes. Intermuscular adipocytes might serve as a benign storage
site for surplus lipid or play a role in disrupting energy homeostasis
as a result of dysregulated lipolysis or secretion of proinﬂammatory
cytokines. This investigation sought to understand the net impact
of local adipocytes on skeletal myocyte metabolism.
RESEARCH DESIGN AND METHODS—Interactions between
these two tissues were modeled using a coculture system com-
posed of primary human adipocytes and human skeletal myo-
tubes derived from lean or obese donors. Metabolic analysis of
myocytes was performed after coculture with lipolytically silent
or activated adipocytes and included transcript and metabolite
proﬁling along with assessment of substrate selection and insulin
action.
RESULTS—Cocultured adipocytes increased myotube mRNA
expression of genes involved in oxidative metabolism, regardless
of the donor and degree of lipolytic activity. Adipocytes in the
basal state sequestered free fatty acids, thereby forcing neigh-
boring myotubes to rely more heavily on glucose fuel. Under this
condition, insulin action was enhanced in myotubes from lean
but not obese donors. In contrast, when exposed to lipolytically
active adipocytes, cocultured myotubes shifted substrate use
in favor of fatty acids, which was accompanied by intracellular
accumulation of triacylglycerol and even-chain acylcarnitines,
decreased glucose oxidation, and modest attenuation of insulin
signaling.
CONCLUSIONS—The effects of cocultured adipocytes on
myocyte substrate selection and insulin action depended on
the metabolic state of the system. These ﬁndings are relevant to
understanding the metabolic consequences of intermuscular
adipogenesis. Diabetes 60:1882–1893, 2011
E
xcess body weight promotes insulin resistance,
systemic dyslipidemia, and elevated circulating
levels of proinﬂammatory cytokines, all hallmarks
of the metabolic syndrome (1,2). Skeletal muscle
is a major tissue responsible for insulin-stimulated glucose
disposal and a principal target of the foregoing disorders
(3–6). These ﬁndings have fueled intense interest in the
metabolic interplay between adipocytes and skeletal myo-
cytes. On the one hand, adipose tissue protects other cell
types from “lipotoxicity” by providing a safe haven for
surplus energy. On the other hand, obesity-induced dys-
regulation of adipocyte lipolysis promotes lipid over-
supply to nonadipocytes (7). Moreover, adipose tissue is
now well recognized as an endocrine organ that informs
the brain and peripheral tissues of changes in whole-body
energy status through a network of circulating “adipo-
kines.” These include peptide hormones, such as leptin,
adiponectin and resistin, as well as cytokines, such as
interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a)( 8 ) .
Obesity lowers circulating levels of insulin-sensitizing
adipokines such as adiponectin while increasing proin-
ﬂammatory molecules, such as IL-6 and TNF-a (9). In
addition to modulating insulin action, these and other
adipokines have been shown to directly regulate lipid me-
tabolism in tissues such as skeletal muscle, heart, liver, and
pancreas (10–12).
Current understanding of adipocyte–myocyte cross-talk
has been shaped in large part by studies examining the
metabolic effects of individual adipokine factors on cul-
tured myocytes or isolated muscle strips. By contrast,
the goal of this work was to model the complex set of
adipocyte-derived signals that regulate skeletal muscle me-
tabolism without confounding effects of other organ sys-
tems. To this end, we used an in vitro coculture system
wherein myocytes were exposed to a physiologic mixture
of free fatty acids and adipokines released by neighboring
adipocytes. We examined the net impact of adipocytes on
transcriptional programming, fuel selection, and insulin
action in cocultured myotubes derived from lean compared
with obese donors. Because distinct adipokine factors can
either enhance or oppose muscle insulin action, we hypoth-
esized that the interactions between cell types might depend
on the metabolic state of the system. In general, our results
supported this hypothesis because we found that lipoly-
tically active adipocytes antagonized myocyte glucose uti-
lization and insulin signaling, whereas adipocytes in the
basal state had the opposite effect. These ﬁndings high-
light the potential utility of this model for investigating
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ORIGINAL ARTICLEmechanisms of metabolic dysregulation or identifying
suitable strategies for intervention.
RESEARCH DESIGN AND METHODS
Materials. Sodium oleate, palmitic acid, 3-isobutyl-1-methylxanthine (IBMX),
cytochalasin B, and L-carnitine were from Sigma-Aldrich (St. Louis, MO). BSA
(fraction V 7.5% cell culture grade) was from Invitrogen (Carlsbad, CA).
Nonesteriﬁed fatty acid and glycerol were measured using kits from Wako
(Richmond, VA) and Sigma-Aldrich, respectively. Adipokines were measured
using ELISA kits from Meso Scale Discovery (Gaithersburg, MD). D-[U-
14C]
Glucose was from Amersham Biosciences (Piscataway, NJ), and [1-
14C]oleic
acid and [
3H]2-D-deoxyglucose were from PerkinElmer Life and Analytical
Sciences (Boston, MA).
Cell culture. Cryopreserved primary human subcutaneous preadipocytes
obtained from Zen-Bio (Research Triangle Park, NC) were maintained and
differentiated according to the supplier’s speciﬁcations. Cells were derived
from pooled lots of six female nondiabetic donors 43.3 6 9.9 years with an
average BMI of 27.6 6 1.1. These cells are functionally similar to non-
commercial primary adipocytes (13). Human skeletal myoblasts were isolated
from lean or severely obese Caucasian women as described previously
(14,15). Myoblasts from four to ﬁve subjects with similar demographics were
pooled to establish a lean and an obese lot that were used for all experiments.
Lean subjects were aged 20.5 6 1.3 years with a BMI of 22.5 6 1.9 kg/m
2,
whereas the obese subjects were aged 29.8 6 8.1 years with a BMI of 44.5 6
1.9 kg/m
2. Fasting insulin (133.3 6 18.8 vs. 47.2 6 4.0 pmol/L) and glucose
(5.5 6 0.4 vs. 4.8 6 0.1 mmol/L) were higher (P , 0.001) in severely obese
subjects compared with lean subjects. Exclusion criteria included hyperten-
sion, vascular disease, type 2 diabetes, and medications that could interfere
with lipid metabolism. The study was approved by the institutional review
board at East Carolina University, and informed and written consent was
obtained from all subjects before participation.
Coculture. Human skeletal myoblasts were plated on 12-well tissue culture
plates coated with collagen I and maintained in growth media until reaching
80% conﬂuence. Differentiation was induced by changing to a low-serum dif-
ferentiation media (DFM). Coculture experiments were initiated on day 6 of
differentiation. Primary human subcutaneous preadipocytes were seeded and
differentiated on inserts from BD Biosciences (San Jose, CA) with a poly-
ethylene terephthalate growth surface containing pores of 3 mmol/L diameter,
allowing passage of glucose, free fatty acids, albumin, and a number of
cytokines (data not shown). Inserts bearing mature adipocytes were washed
and transferred to 12-well plates containing human myotubes and DFM,
without affecting adipocyte viability (data not shown). Cocultures were
maintained for 24 or 96 h in DFM supplemented with 0.5% BSA and 2 mmol/L
L-carnitine 6 100 mmol/L IBMX to stimulate lipolysis. Control myotubes were
maintained under identical conditions but without adipocytes. Thus, IBMX
exposure was matched in the no-adipocyte control compared with the
cocultured myotubes.
Glucose and fatty acid metabolism. Glucose oxidation and glycogen syn-
thesis rates were determined as described previously (16). Insulin stimulation
of glycogen synthesis was assessed after 2 h of serum starvation followed by
incubation with a-minimal essential medium (a-MEM) containing D-[UL-
14C]
glucose 6 100 nmol/L insulin for an additional 2 h. [
3H]2-D-Deoxyglucose
uptake was measured after 3 h of serum starvation 6 200 nmol/L insulin. Fatty
acid oxidation assays were performed with 0.10 mmol/L [1-
14C]oleate as de-
scribed previously (17).
Acylcarnitine proﬁling and lipid analyses. Human skeletal myotubes were
washed with PBS, placed in liquid nitrogen to ﬂash-freeze the cells, and then
sonicated at 2.5 W for 5 s in 250 mL deionized water (18). Acylcarnitines were
measured by direct-injection electrospray tandem mass spectrometry, using
a Micromass Quattro Micro system equipped with a model 2777 autosampler,
a model 1525 high-pressure liquid chromatography solvent delivery system,
and a data system running 4.0 MassLynx software (Waters Corporation, Milford,
MA). Triacylglycerol and diacylglycerol were extracted in methanol–chloroform
and separated by thin-layer chromatography; analysis of esteriﬁed fatty acids
was performed by gas chromatography methodologies as described previously
(19). Ceramides were extracted as described previously (20) and analyzed by
ﬂow injection tandem mass spectrometry using a Micromass Quattro spec-
trometer (Waters Corporation) for precursors of m/z 264.
Real-time PCR. RNA was extracted from myotubes using RNeasy (Qiagen,
Valencia, CA) quantiﬁed by RiboGreen (Molecular Probes, Eugene, OR), and
cDNA was synthesized from 1 mg RNA using the IScriptcDNA synthesis kit
(Bio-Rad Laboratories, Hercules, CA). Gene expression was determined by
real-time quantitative PCR using a Prism 7000 with TaqMan chemistry (Applied
Biosystems, Foster City, CA).
Insulin signaling. After removing adipocytes, myotubes were washed, serum-
starved for 5 h, and then incubated 610 nmol/L insulin for 10 min at 37°C in
a humidiﬁed atmosphere of 5% CO2 before collecting cell lysates. After SDS-
PAGE (Bio-Rad Laboratories) and protein transfer to polyvinylidene diﬂuoride
membranes, blots were probed overnight with either anti-phospho-Akt Ser
473
or anti-phospho–glycogen synthase kinase-3b (GSK-3b)S e r
9 antibody from
Cell Signaling Technology (Danvers, MA) followed by incubation with horse-
radish peroxidase–conjugated Ig-G antibodies and ECL Plus chemiluminescence
detection kit. Visualized bands were quantiﬁed using ImageQuant software
(Amersham Biosciences) and normalized to total protein determined by
MemCode Reversible Protein Stain (Thermo Fisher Scientiﬁc, Rockford, IL),
total Akt, tubulin, and GSK-3b, which were probed after stripping.
RESULTS
In vitro modeling of the adipogenic phenotype of
insulin-resistant skeletal muscle. Computed tomogra-
phy was used to illustrate (Fig. 1A and B) the effect of
obesity on the physical relationship between adipose tis-
sue and skeletal muscle of the lower limb (21). Obesity-
related expansion of adipose tissue mass was evident in
the subcutaneous and intermuscular compartments. This
pronounced adipocyte inﬁltration within and surrounding
the thigh muscle underscores the importance of under-
standing the interplay between adipocyte proliferation and
skeletal muscle function. In an attempt to model this patho-
physiologic phenomenon in vitro, we developed a cocul-
ture system using primary human myotubes and primary
human adipocytes. Under basal conditions, the adipocytes
decreased free fatty acid levels in the culture medium from
a baseline of 25 mmol/L in the myocyte-only control to 18
mmol/L after 24 h of coculture (P , 0.05) (Fig. 1C), pre-
sumably reﬂecting uptake and sequestration of fat into the
adipocyte triacylglycerol (TAG) pool. To drive release of
free fatty acids from the adipocytes into the coculture me-
dium, we added IBMX as a lipolytic stimulus (Fig. 1C).
Under stimulated conditions, the fatty acid concentration
of the coculture medium increased approximately fourfold
to 93 mmol/L (P , 0.05). Determination of individual free
fatty acid species by gas chromatography–mass spectrom-
etry (Fig. 1D) showed that palmitate (c16:0) and oleate
(c18:1) were the predominant long-chain fatty acids re-
leased by the adipocytes, whereas myristate (c14:0), pal-
mitoleate (c16:1), and stearate (c18:0) were present at
lower levels. This fatty acid proﬁle resembled that found in
human sera, with the exception of the essential fatty acids,
linoleic acid (18:2), and a-linolenic acid (18:3). The human
adipocytes also released measurable quantities of prom-
inent adipokines, such as leptin, adiponectin, IL-6, and
TNF-a (Fig. 1E), although the levels detected in the culture
system were lower than those measured previously in hu-
man sera (22). Adipocyte secretion of these adipokines was
not altered by IBMX.
Effect of cocultured adipocytes on myocyte glucose
disposal. Fully differentiated myotubes were cocultured
with differentiated adipocytes for 24 h in the absence or
presence of IMBX. To examine myotube adaptation to
coculture, the system was then disassembled and meta-
bolic assays were performed in the absence of adipocytes,
using fresh culture medium. In the basal (nonstimulated)
state, the presence of adipocytes lowered rates of glyco-
gen synthesis (26 and 40%) in myotubes from lean and
obese donors, respectively (Fig. 2A and E), but did not
affect glucose oxidation (Fig. 2C and G). By contrast, ex-
posure to IBMX-stimulated (lipolytically active) adipocytes
decreased glucose oxidation to 53 and 41% in myotubes
from lean and obese donors, respectively (Fig. 2D and H);
however, glycogen synthesis was maintained at rates
similar to those of the control group (Fig. 2B and F).
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oxidation. We questioned whether the adipocyte-mediated
decline in glucose utilization might be secondary to a re-
ciprocal increase in fat oxidation. As in our previous
reports (15,17), rates of fatty acid oxidation were lower in
myotubes derived from obese compared with lean donors
(Fig. 3A and C); however, 24-h exposure to adipocytes
did not affect oxidation rates of exogenously supplied
[
14C]oleate, regardless of the lipolytic state of the coculture
system (Fig. 3A–D). Because glucose metabolism (Fig. 2)
was assessed in the absence of exogenously supplied fatty
acids, we next sought to determine whether intracellular
lipids might have contributed to a shift in substrate selec-
tion. To test this possibility, we examined myotube glucose
metabolism in the presence of etomoxir, a potent phar-
macologic inhibitor of b-oxidation. Indeed, addition of eto-
moxir during a 2-h incubation with [
14C]glucose increased
production of radiolabeled CO2 by myocytes that had un-
dergone coculture to rates observed in the control cells
(Fig. 3E and F). These results strongly imply that prior ex-
posure of myotubes to lipolytic adipocytes increased ac-
cumulation, turnover, and catabolism of intracellular lipids,
thereby reducing glucose oxidation.
A more comprehensive assessment of mitochondrial me-
tabolism was performed using mass spectrometry–based
acylcarnitine proﬁling. Information gained from this assay
can be used to infer changes in metabolic ﬂux and substrate
selection without bias as to exogenous versus intracellular
FIG. 1. Adipocyte-myocyte coculture model. Computed tomography images of the thigh comparing (A) a young healthy female subject with (B)a n
older, obese female subject. a: Thigh muscle; b: subcutaneous adipose tissue; c: intermuscular adipose tissue. C: Free fatty acid concentration of
the culture medium after 24-h exposure to basal (unstimulated) or stimulated (+100 mM IBMX) human adipocytes compared with no adipocytes.
D: Individual free fatty acids in culture medium exposed to stimulated adipocytes for 24 h compared with no adipocytes. E: Adipokine concentrations
in the culture medium after 24-h exposure to basal (unstimulated) or stimulated (+100 mM IBMX) human adipocytes. Results are expressed as
mean 6 SEM and representative of at least two experiments performed in triplicate. *Signiﬁcant (P < 0.05) effect of adipocyte exposure analyzed
by Student t test. FA, fatty acid. (A high-quality color representation of this ﬁgure is available in the online issue.)
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creased a small subset of acylcarnitine species (Fig. 4A
and B), including oleyl carnitine (C18:1) and propionyl-
carnitine (C3) in the lean group and acetylcarnitine (C2) in
the obese group, ﬁtting with the fatty acid–lowering effect
of the adipocytes (Fig. 1C). In the obese group, adipocytes
increased myotube levels of isovaleryl-carnitine (C5), a
metabolite that derives from leucine catabolism. By con-
trast, exposure of myotubes to stimulated adipocytes
resulted in cellular accumulation of most even-chain acyl-
carnitines, whereas several odd-chain (amino acid-derived)
species declined (Fig. 5A and B). This pattern is consistent
with a substrate shift toward increased b-oxidation and
reduced catabolism of both glucose (Fig. 2) and amino
acids. The acylcarnitine proﬁles were similar between myo-
tubes from lean and obese donors (Fig. 5A and B); however,
the latter cohort displayed marked accumulation of ace-
tylcarnitine (C2), regardless of the treatment. In addition,
myotubes from obese donors had a more pronounced in-
crease in medium-chain acylcarnitine levels in response to
adipocyte exposure, such that the ratio of total medium- to
long-chain acylcarnitines increased from 1.2 in the no adi-
pocyte control group to 2.4 after coculture (Fig. 5B). This
proﬁle is consistent with a potential ﬂux limitation at
medium-chain acyl-CoA dehydrogenase (23).
Effect of cocultured adipocytes on myocyte gene
expression. In previous studies, we found that exposure
of cultured myotubes to high concentrations of fatty acid
increases expression of genes involved in b-oxidation (24).
In the current study, we found a similar effect of adipocyte
exposure. Thus, the coculture condition induced myotube
mRNA expression of several genes that promote fatty acid
FIG. 2. Adipocyte exposure alters glucose metabolism in primary human myotubes. Primary human skeletal myotubes from lean (A–D) and se-
verely obese (E–H) women were maintained 24 h in the absence or presence of human adipocytes under basal or stimulated (100 mmol/L IBMX)
conditions. After 24 h of coculture, adipocytes were removed, and myotubes were washed and incubated 2 h in a-MEM containing 2 mCi/mL
D-[U-
14C]glucose. Rates of glycogen synthesis and glucose oxidation were determined by measuring label incorporation into glycogen (A, B, E, and
F) and CO2 (C, D, G, and H). Results are expressed as mean 6 SEM and representative of at least three experiments performed in triplicate.
*Signiﬁcant (P < 0.05) effect of adipocyte exposure analyzed by Student t test.
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nase kinase 4 (PDK4), peroxisome proliferator–activated
receptor g coactivator 1-a (PGC1-a), very long-chain acyl-
CoA dehydrogenase, and adipocyte triglyceride lipase
(ATGL). This effect was most pronounced when lipolysis
was stimulated. However, it is noteworthy that several
genes, including PDK4, PGC1-a, and ATGL, were upregu-
lated even in the basal condition, suggesting that adipocyte-
derived factors in addition to free fatty acids contribute
to transcriptional remodeling of the myotubes. Genes in-
volved in glucose metabolism were also affected by adi-
pocyte coculture (Fig. 6C and D). The coculture condition
increased myotube mRNA expression of the glucose
transporters 1 and 4, as well as lactate dehydrogenase a,
but lowered mRNA expression of the glycolytic enzyme
hexokinase 2. These changes were most pronounced when
myotubes from lean subjects were exposed to basal adi-
pocytes. It is also notable that lipolytically stimulated
adipocytes caused a three- to fourfold increase in myotube
expression of thioredoxin interacting protein, a redox-
regulatory protein that has been implicated as a negative
regulator of glucose homeostasis (25). In general, the
transcriptional responses were similar between the lean
and obese groups, with a few subtle distinctions. For ex-
ample, adipocyte-mediated upregulation of malonyl-CoA
decarboxylase, carnitine palmitoyltransferase 1b (CPT1b),
PGC1-a, and thioredoxin-interacting protein was more
robust in the obese cohort, whereas the effects on the
glucose transporters were more pronounced in the lean
group.
FIG. 3. Effects of adipocyte exposure on fatty acid metabolism in primary human myotubes. Primary human skeletal myotubes from lean (A, B,
and E) and severely obese (C, D, and F) women were maintained 24 h in the absence or presence of human adipocytes under basal or stimulated
(100 mmol/L IBMX) conditions. After 24 h of coculture, adipocytes were removed, and myotubes were washed and incubated 2 h with a-MEM
containing 100 mmol/L [
14C]oleate (A–D) or 5 mmol/L [
14C]glucose (E and F). Label incorporation into CO2 was measured to assess oxidation rates
of fatty acid and glucose, respectively. The addition of 100 mmol/L etomoxir during the glucose oxidation assay (E and F) was used to block
oxidation of intracellular lipids. Results are expressed as mean 6 SEM and representative of at least three experiments performed in triplicate.
*Signiﬁcant (P < 0.05) effect of adipocyte exposure analyzed by Student t test.
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action. In myotubes from lean donors, 24-h exposure to
basal adipocytes enhanced insulin-stimulated phosphory-
lation of Akt at Ser473 and rates of glycogen synthesis by
1.5- and 1.2-fold, respectively (P , 0.05) (Fig. 7A and C). In
the no-adipocyte control group, pretreatment with IBMX
ampliﬁed insulin-mediated activation of Akt by 66%
compared with the no IBMX condition. Likewise, the addi-
tion of IBMX resulted in a 17% enhancement of insulin-
stimulated glycogen synthesis. In the stimulated condition,
the presence of adipocytes did not affect pAkt but did
result in a modest 17% enhancement of insulin-stimulated
glycogen synthesis (Fig. 7B and D), possibly because of
glucose repartitioning from oxidation to storage (Fig. 2).
FIG. 4. Adipocyte exposure alters acylcarnitine accumulation in primary human myotubes. Primary human skeletal myotubes from lean (A) and
severely obese (B) women were maintained 24 h in the absence or presence of human adipocytes under basal conditions. After 24 h of coculture,
adipocytes were removed, myotubes were washed, and cell lysates were prepared for acylcarnitine proﬁling by mass spectrometry. C3DC and
C5OH are isobaric species. The ratio of total medium-chain relative to total long-chain acylcarnitines was calculated to assess potential ﬂux
limitations at the medium-chain acyl-CoA dehydrogenase step of b-oxidation. Results are expressed as mean 6 SEM and representative of at least
three experiments performed in triplicate. Abbreviations reﬂect carbon chain length (e.g., C2, acetylcarnitine). DC, dicarboxylic acid; OH, hy-
droxylated species. *Signiﬁcant (P < 0.05) effect of adipocyte exposure analyzed by Student t test.
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insulin-stimulated phosphorylation of GSK-3b (Supple-
mentary Fig. 1A and B). Exposure of myotubes to cocul-
tured adipocytes did not affect insulin-stimulated glucose
uptake (Supplementary Fig. 2A). Compared with the lean
group, insulin responsiveness in myotubes from obese
donors was markedly impaired (Fig. 7E–H, Supplementary
Fig. 1C and D). It is noteworthy that neither IBMX stimu-
lation nor the presence of adipocytes was sufﬁcient to
enhance insulin action in the obese cohort.
Myocyte responses to prolonged adipocyte exposure.
Because obesity-related metabolic derangements develop
secondary to chronic overnutrition, we questioned whether
prolonged exposure to lipolytic adipocytes might provoke
a more diabetogenic outcome. Therefore, we exposed myo-
tubes from lean subjects to stimulated coculture conditions
for 96 h, which caused a modest but signiﬁcant 21% reduction
in insulin-stimulated Akt phosphorylation (Fig. 8A) and
a decline in GSK-3b phosphorylation (Fig. 8B), without
affecting glucose uptake (Supplementary Fig. 2B). Pro-
longed exposure to adipocytes caused a marked 6.8-fold
increase in myotube TAG content compared with the 35%
increase (P , 0.05) that occurred after 24 h of coculture
(Fig. 8C, Supplementary Fig. 3). Although diacylglycerol
levels trended higher in cocultured myotubes, differences
between groups did not reach statistical signiﬁcance (Fig.
8D, Supplementary Fig. 3), and concentrations of total
ceramides (Fig. 8E) and several subspecies (Supplementary
Fig. 3) were 29% lower after coculture (P , 0.05). We then
examined concurrent changes in the cellular acylcarnitine
proﬁle. Compared with the short-term (24-h) exposure (Fig.
5A), 96 h of coculture resulted in a more robust accumu-
lation of medium-chain acylcarnitines (Fig. 8F), resembling
the proﬁle of myotubes from obese subjects (Fig. 5B).
FIG. 5. Effect of stimulated adipocyte exposure on acylcarnitine accumulation in primary human myotubes. Primary human skeletal myotubes from
lean (A) and severely obese (B) women were maintained 24 h in the absence or presence of human adipocytes under stimulated (100 mmol/L
IBMX) conditions. After 24 h of coculture, adipocytes were removed, myotubes were washed, and cell lysates were prepared for acylcarnitine
proﬁling by mass spectrometry. C3DC and C5OH are isobaric species. The ratio of total medium-chain relative to total long-chain acylcarnitines
was calculated to assess potential ﬂux limitations at the medium-chain acyl-CoA dehydrogenase step of b-oxidation. Results are expressed as
mean 6 SEM and are representative of at least three experiments performed in triplicate. Abbreviations reﬂect carbon chain length (e.g., C2,
acetylcarnitine). DC, dicarboxylic acid; OH, hydroxylated species. *Signiﬁcant (P < 0.05) effect of adipocyte exposure analyzed by Student t test.
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This investigation examined metabolic reprogramming of
primary human skeletal myotubes from lean and obese
donors in response to cocultured adipocytes. The most
salient outcome of the study was that the adipocytes en-
couraged myotubes to use fatty acids rather than glucose
as an oxidative fuel. The adipocyte-induced shift in sub-
strate preference was mediated at multiple levels. First,
the coculture conditions increased mRNA abundance of
several genes that promote fatty acid catabolism, including
PDK4, PGC-1a, very long-chain acyl-CoA dehydrogenase,
and ATGL. This effect was strongest when myocytes were
exposed to lipolytically active adipocytes, consistent with
the notion that fatty acids and their metabolites induce
muscle expression of oxidative enzymes by acting as
ligands for the PPAR family of transcription factors (26).
However, it is noteworthy that changes in gene expres-
sion occurred even under lipolytically silent conditions,
suggesting that adipocyte-derived agents other than fatty
acids can affect myocyte remodeling at the genomic level.
Although cocultured myotubes were transcriptionally
primed for b-oxidation, a measurable switch in fuel selec-
tion occurred only when a surfeit of fatty acids was made
available via lipolytic stimulation. This conclusion stems
from both the acylcarnitine proﬁles and the coincident
decline in glucose oxidation. Cellular levels of acylcar-
nitines, which are byproducts of mitochondrial catabolism,
ﬂuctuate in response to changes in substrate availability
and ﬂux limitations at speciﬁc metabolic enzymes (23).
Long-chain acylcarnitines are produced by the outer mi-
tochondrial membrane enzyme, CPT1, which catalyzes the
ﬁrst committed step in b-oxidation. The increase in myo-
cyte long-chain acylcarnitines on coculture with stimulated
adipocytes could reﬂect increased fatty acid availability,
increased CPT1 activity, or a ﬂux limitation immediately
downstream of this enzyme. It is noteworthy that the CPT1
inhibitor (etomoxir) abolished adipocyte-induced suppres-
sion of myotube glucose oxidation, even though the assay
was performed after the coculture system was disassembled.
Taken together, these observations suggest that persistent
trafﬁcking of fatty acids from perimuscular adipocytes
to intramyocellular storage pools (Supplementary Fig. 3)
contribute to reduced glucose utilization in the obese state
(27,28).
Exposure to nonstimulated adipocytes lowered myotube
levels of selected acylcarnitine species, possibly reﬂecting
a reduction in metabolic load. Under these conditions,
cocultured adipocytes potentiated insulin stimulation of
pAkt and glycogen synthesis (Fig. 7). This enhancement
might have occurred secondary to changes in fuel metab-
olism or the actions of insulin-sensitizing adipokines (10).
By contrast, prolonged exposure (96 h) to the lipolytic
condition resulted in a shift toward an insulin-resistant
phenotype, evidenced by a modest but signiﬁcant attenua-
tion of insulin-stimulated Akt phosphorylation. The severity
of adipocyte-induced insulin resistance in the current in-
vestigation was modest compared with studies in which
cultured myotubes were incubated with high concentra-
tions of palmitate (29,30). This discrepancy could stem from
multiple factors, including the nature of the lipid load. We
reason that the coculture model bears closer resemblance
to in vivo physiology because myotubes are exposed to
a steady release of mixed fatty acids, rather than a large
bolus of a single fatty acid. Last, we found that adipocyte-
induced perturbations in glucose metabolism progressed
from substrate switching during short-term coculture to
impaired Akt signaling after longer exposure. This sce-
nario is similar to the development of diet-induced insulin
resistance in both animals and humans (31,32).
To our knowledge, only one other group has examined
insulin signaling in human myocytes after coculture with
adipocytes (33,34). Investigators reported that 48 h of co-
culture caused a mild form of insulin resistance result-
ing in reduced stimulation of insulin receptor substrate-1
FIG. 6. Adipocyte exposure alters myotube mRNA expression. Primary
human skeletal myotubes from lean (A and C) and severely obese (B
and D) women were maintained 24 h in the absence or presence of
human adipocytes under basal or stimulated (100 mmol/L IBMX) con-
ditions. After 24 h of coculture, adipocytes were removed and myotubes
were washed and harvested for RNA extraction. Myotube expression of
candidate mRNAs involved in fatty acid oxidation (A and B) or glucose
metabolism (C and D) was measured by real-time quantitative PCR and
normalized to mRNA levels of 18S. Data are expressed as mean 6 SEM
of the fold change in mRNA abundance relative to the control cells that
were not exposed to adipocytes (dashed line). Results are represen-
tative of at least three experiments performed in triplicate. *Signiﬁ-
cant (P < 0.05) effect of adipocyte exposure analyzed by Student
t test. CS, citrate synthase; Glut1, glucose transporter 1; Glut4, glucose
transporter 4; HK1, hexokinase 1; HK2, hexokinase 2; LDHa, lactate
dehydrogenase a; LDHb, lactate dehydrogenase b; MCD, malonyl-CoA
decarboxylase; VLAD, very long-chain acyl-CoA dehydrogenase; TXNIP,
thioredoxin-interacting protein.
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signaling in human myotubes incubated with adipocyte-
conditioned medium was reversed by pharmacologic
inhibition of inhibitor kB kinase, thereby implicating in-
ﬂammatory stress as an underlying mechanism (32). These
earlier studies did not evaluate different lipolytic condi-
tions or changes in myocyte energy metabolism. In the
current study, adipocyte stimulation proved to be a de-
termining factor that inﬂuenced metabolic outcomes. Se-
cretion of several prominent adipokines was unchanged by
IBMX (Fig. 1), although the compound could have affected
other cytokines and peptide hormones known to act on
muscle (35,36). Nonetheless, our data strongly imply that
adipocyte lipolysis contributed to changes in myotube
energy metabolism. This result is relevant to reports that
have identiﬁed dysregulated lipolysis as an early feature
of the metabolic syndrome (37,38). Our observation that
relatively low concentrations of adipocyte-derived fatty
acids were sufﬁcient to coerce myotubes into lipid oxida-
tion underscores the potential importance of localized li-
polysis in provoking glucose disuse.
The reciprocal relationship between lipid and glucose
oxidation was ﬁrst described by Randle et al. (39,40) as the
“glucose-fatty acid cycle,” which holds that b-oxidation
suppresses glycolysis and pyruvate oxidation by inhibiting
hexokinase, phosphofructokinase, and pyruvate dehydro-
genase (40). Another popular theory to explain obesity-
induced glucose intolerance proposes that fatty acid
oversupply causes cellular accumulation of insulin-
desensitizing lipid molecules, such as diacylglycerol and
FIG. 7. Coculture exposure for 24 h enhances myotube insulin response. Primary human skeletal myotubes from lean (A–D) and severely obese (E–H)
women were maintained 24 h in the absence or presence of human adipocytes under basal or stimulated (100 mmol/L IBMX) conditions.
Adipocytes were removed, and myotubes were washed and incubated with a-MEM 6 100 nmol/L insulin for 10 min. Protein extracts were used for
immunoblot analysis of Akt Ser
473 phosphorylation, corrected for total protein loading using Memcode staining. Measurement of total Akt
protein showed no treatment effects. Rates of glycogen synthesis were measured after a 2-h incubation with a-MEM containing 5 mmol/L
[
14C]glucose 6 100 nmol/L insulin. Results are expressed as mean 6 SEM and representative of at least three experiments performed in
triplicate. *Signiﬁcant (P < 0.05) effect of adipocyte exposure analyzed by Student t test.
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tube content of these speciﬁc lipid species was either
unchanged or decreased after prolonged exposure to the
coculture conditions, despite marked elevations in tri-
acylglycerol levels. Moreover, myotubes from obese sub-
jects remained profoundly insulin resistant even when
grown in the absence of fatty acids or adipocytes, again
hinting at alternative mechanisms. Recent animal studies
suggested that lipid-induced antagonism of glucose disposal
might stem from a mitochondrial-derived signal that closely
associates with intramuscular acylcarnitine accumulation
(24,43). In light of these earlier reports, it is noteworthy
that the current study also revealed an intriguing connec-
tion between impaired insulin signaling after 96-h expo-
sure to lipolytic adipocytes and myocyte accumulation of
medium-chain acylcarnitines. Likewise, the insulin-resistant
phenotype of the obese myotubes was accompanied by
a more pronounced accumulation of short- and medium-
chain acylcarnitines. Although evidence that acylcarni-
tines play a direct role in mediating glucose intolerance is
FIG. 8. Chronic coculture exposure dampens myotube insulin response. Primary human skeletal myotubes from lean women were maintained 96 h
in the absence or presence of human adipocytes under stimulated (100 mmol/L IBMX) conditions. Adipocytes were removed, and myotubes
were washed and incubated with a-MEM 6 100 nmol/L insulin for 10 min. A: Protein extracts were used for immunoblot analysis of Akt Ser
473
phosphorylation, corrected for total protein loading using Memcode staining. Measurement of total Akt protein showed no treatment effects.
B: GSK-3b Ser
9 phosphorylation, corrected for total protein using tubulin staining. C–F: Myotube extracts were used for measurement of total
triacylglycerol (C), total diacylglycerol (D), total ceramide (E), and acylcarnitine proﬁling (F). C3DC and C5OH are isobaric species. The ratio of
total medium-chain relative to total long-chain acylcarnitines was calculated to assess potential ﬂux limitations at the medium-chain acyl-CoA
dehydrogenase step of b-oxidation. Results are expressed as mean 6 SEM and representative of at least three experiments performed in triplicate,
except for the TAG, DAG, and ceramides, which represent two independent experiments performed in quadruplicate. *Signiﬁcant (P < 0.05) effect
of adipocyte exposure analyzed by Student t test. Abbreviations reﬂect carbon chain length (e.g., C2, acetylcarnitine). DC, dicarboxylic acid;
OH, hydroxylated species.
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chondrial events that are known to inﬂuence insulin sig-
naling, such as production of reactive oxygen species or
perturbations in redox balance (25,44,45).
Whereas the current investigation was executed using
pooled lots of human myocytes, our previous work revealed
compelling between-group differences when analyses were
performed using cell cultures established from individual
donors (15,46). In aggregate, these studies have shown that
myotubes from obese compared with lean donors have
lower rates of complete fat oxidation, increased acylcarni-
tine accumulation, elevated rates of TAG synthesis on lipid
exposure, and impaired insulin-stimulated phosphorylation
of Akt. A novel and potentially important ﬁnding from the
coculture model is that the insulin-sensitizing effects of
basal adipocytes were observed only in myotubes derived
from lean donors, possibly reﬂecting an inherent resistance
to antidiabetic adipokines in myotubes isolated from obese
donors. This interpretation is supported by previous studies
showing that myotubes from obese donors are refractory to
the salutary effects of adiponectin (47,48).
In conclusion, we have developed and comprehen-
sively characterized a novel coculture system designed
to mimic the physiologic interactions between skeletal
myoﬁbers and intermuscular adipocytes. One caveat of
the model is that the lipolytic agent (IBMX) used to in-
crease cAMP levels in adipocytes has a similar effect on
other cell types and was found in the current study to
enhance myocyte insulin responsiveness (Fig. 7). Thus,
it is noteworthy that our reference to a stimulated state
refers to both compartments of the model. Although IBMX
might have modiﬁed myocyte responses to the coculture,
we reason that the stimulated condition is physiologi-
cally relevant given that obesity is often accompanied by
a heightened sympathetic tone (49–51). Studies using
this model provided new and important insights re-
garding the net metabolic impact of local adipocytes on
neighboring myocytes. This work sets the stage for fu-
ture investigations seeking to elucidate the molecular
connections between increased adiposity and muscle
dysfunction.
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